$LJPC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LA JOLLA PHARMACEUTICAL CO. Get notifications about new insider transactions in LA JOLLA PHARMACEUTICAL CO for free.
Page: < prev 1 2 3 4 5 6 ... 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.85 | 141 | 966 | 141 | |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.82 | 141 | 821 | 80,420 | 80.3 K to 80.4 K (+0.18 %) |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.85 | 282 | 1,932 | 282 | |
| Feb 04 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.82 | 282 | 1,641 | 8,015 | 7.7 K to 8 K (+3.65 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.80 | 75,003 | 509,833 | 8,080,345 | 8 M to 8.1 M (+0.94 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.75 | 13,292 | 89,705 | 8,005,342 | 8 M to 8 M (+0.17 %) |
| Feb 03 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.72 | 81,475 | 547,431 | 7,992,050 | 7.9 M to 8 M (+1.03 %) |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 7.88 | 498 | 3,924 | 498 | |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 6.70 | 498 | 3,337 | 7,823 | 7.3 K to 7.8 K (+6.80 %) |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.88 | 692 | 5,453 | 692 | |
| Jan 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.70 | 692 | 4,636 | 80,279 | 79.6 K to 80.3 K (+0.87 %) |
| Jan 16 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Buy | P | 8.23 | 3,000 | 24,677 | 6,545 | 3.5 K to 6.5 K (+84.63 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 6.66 | 1,253,878 | 8,351,580 | 7,910,575 | 6.7 M to 7.9 M (+18.84 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.70 | 717,804 | 4,090,909 | 6,656,697 | 5.9 M to 6.7 M (+12.09 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.27 | 400,339 | 2,111,748 | 5,938,893 | 5.5 M to 5.9 M (+7.23 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 4.80 | 599,661 | 2,880,232 | 5,538,554 | 4.9 M to 5.5 M (+12.14 %) |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Jan 13 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.25 | 30,000 | 157,500 | 30,000 | |
| Dec 23 2019 | LJPC | LA JOLLA PHARMACEU ... | Rosen Robert | Director | Option Exercise | A | 3.93 | 12,000 | 47,160 | 12,000 | |
| Dec 23 2019 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Option Exercise | A | 3.93 | 12,000 | 47,160 | 12,000 | |
| Dec 23 2019 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 3.93 | 12,000 | 47,160 | 12,000 | |
| Dec 23 2019 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 3.93 | 12,000 | 47,160 | 12,000 | |
| Dec 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 3.35 | 112 | 375 | 112 | |
| Dec 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 2.85 | 112 | 319 | 4,802 | 4.7 K to 4.8 K (+2.39 %) |
| Dec 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 3.35 | 201 | 673 | 201 | |
| Dec 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 2.85 | 201 | 573 | 7,153 | 7 K to 7.2 K (+2.89 %) |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 2.74 | 247 | 677 | 247 | |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 2.33 | 247 | 576 | 6,952 | 6.7 K to 7 K (+3.68 %) |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 2.74 | 138 | 378 | 138 | |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 2.33 | 138 | 322 | 4,690 | 4.6 K to 4.7 K (+3.03 %) |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 2.74 | 17 | 47 | 17 | |
| Dec 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 2.33 | 17 | 40 | 3,545 | 3.5 K to 3.5 K (+0.48 %) |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.02 | 118 | 710 | 118 | |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.12 | 118 | 604 | 79,587 | 79.5 K to 79.6 K (+0.15 %) |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.02 | 311 | 1,872 | 311 | |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.12 | 311 | 1,592 | 3,528 | 3.2 K to 3.5 K (+9.67 %) |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.02 | 62 | 373 | 62 | |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.12 | 62 | 317 | 4,552 | 4.5 K to 4.6 K (+1.38 %) |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.02 | 111 | 668 | 111 | |
| Nov 19 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.12 | 111 | 568 | 6,705 | 6.6 K to 6.7 K (+1.68 %) |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 7.02 | 133 | 934 | 133 | |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.96 | 133 | 793 | 79,469 | 79.3 K to 79.5 K (+0.17 %) |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 7.02 | 267 | 1,874 | 267 | |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.96 | 267 | 1,591 | 3,217 | 3 K to 3.2 K (+9.05 %) |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 7.02 | 96 | 674 | 96 | |
| Nov 05 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.96 | 96 | 572 | 6,594 | 6.5 K to 6.6 K (+1.48 %) |
| Oct 24 2019 | LJPC | LA JOLLA PHARMACEU ... | RAMSAY DAVID A | Director | Option Exercise | A | 8.43 | 18,000 | 151,740 | 18,000 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.38 | 224 | 1,877 | 224 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.12 | 224 | 1,595 | 2,950 | 2.7 K to 3 K (+8.22 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.38 | 81 | 679 | 81 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.12 | 81 | 577 | 6,498 | 6.4 K to 6.5 K (+1.26 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.38 | 224 | 1,877 | 224 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.12 | 224 | 1,595 | 4,223 | 4 K to 4.2 K (+5.60 %) |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.38 | 112 | 939 | 112 | |
| Oct 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.12 | 112 | 797 | 79,336 | 79.2 K to 79.3 K (+0.14 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.80 | 107 | 942 | 107 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.48 | 107 | 800 | 79,224 | 79.1 K to 79.2 K (+0.14 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.80 | 213 | 1,874 | 213 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.48 | 213 | 1,593 | 3,999 | 3.8 K to 4 K (+5.63 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.80 | 76 | 669 | 76 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.48 | 76 | 568 | 6,417 | 6.3 K to 6.4 K (+1.20 %) |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.80 | 213 | 1,874 | 213 | |
| Oct 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.48 | 213 | 1,593 | 2,726 | 2.5 K to 2.7 K (+8.48 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 10.92 | 85 | 928 | 85 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 9.28 | 85 | 789 | 79,117 | 79 K to 79.1 K (+0.11 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 10.92 | 171 | 1,867 | 171 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 9.28 | 171 | 1,587 | 3,786 | 3.6 K to 3.8 K (+4.73 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 10.92 | 171 | 1,867 | 171 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 9.28 | 171 | 1,587 | 2,513 | 2.3 K to 2.5 K (+7.30 %) |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 10.92 | 62 | 677 | 62 | |
| Sep 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 9.28 | 62 | 575 | 6,341 | 6.3 K to 6.3 K (+0.99 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.57 | 196 | 1,876 | 196 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.13 | 196 | 1,593 | 3,615 | 3.4 K to 3.6 K (+5.73 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.57 | 196 | 1,876 | 196 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.13 | 196 | 1,593 | 2,342 | 2.1 K to 2.3 K (+9.13 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.57 | 70 | 670 | 70 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 8.13 | 70 | 569 | 6,279 | 6.2 K to 6.3 K (+1.13 %) |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.57 | 98 | 938 | 98 | |
| Sep 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.13 | 98 | 797 | 79,032 | 78.9 K to 79 K (+0.12 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.43 | 99 | 934 | 99 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.02 | 99 | 794 | 78,934 | 78.8 K to 78.9 K (+0.13 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.43 | 72 | 679 | 72 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 8.02 | 72 | 577 | 6,209 | 6.1 K to 6.2 K (+1.17 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.43 | 198 | 1,867 | 198 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.02 | 198 | 1,588 | 3,419 | 3.2 K to 3.4 K (+6.15 %) |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.43 | 198 | 1,867 | 198 | |
| Aug 16 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.02 | 198 | 1,588 | 2,146 | 1.9 K to 2.1 K (+10.16 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.36 | 224 | 1,873 | 224 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.11 | 224 | 1,593 | 3,221 | 3 K to 3.2 K (+7.47 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.36 | 80 | 669 | 80 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.11 | 80 | 569 | 6,137 | 6.1 K to 6.1 K (+1.32 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.36 | 224 | 1,873 | 224 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.11 | 224 | 1,593 | 1,948 | 1.7 K to 1.9 K (+12.99 %) |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.36 | 112 | 936 | 112 | |
| Aug 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.11 | 112 | 796 | 78,835 | 78.7 K to 78.8 K (+0.14 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.24 | 203 | 1,876 | 203 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.85 | 203 | 1,594 | 2,997 | 2.8 K to 3 K (+7.27 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.24 | 203 | 1,876 | 203 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.85 | 203 | 1,594 | 1,724 | 1.5 K to 1.7 K (+13.35 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.24 | 102 | 942 | 102 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.85 | 102 | 801 | 78,723 | 78.6 K to 78.7 K (+0.13 %) |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.24 | 73 | 675 | 73 | |
| Jul 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.85 | 73 | 573 | 6,057 | 6 K to 6.1 K (+1.22 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.25 | 202 | 1,869 | 202 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 7.86 | 202 | 1,588 | 2,794 | 2.6 K to 2.8 K (+7.79 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.25 | 101 | 934 | 101 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 7.86 | 101 | 794 | 78,621 | 78.5 K to 78.6 K (+0.13 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.25 | 202 | 1,869 | 202 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 7.86 | 202 | 1,588 | 1,521 | 1.3 K to 1.5 K (+15.31 %) |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.25 | 73 | 675 | 73 | |
| Jul 01 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 7.86 | 73 | 574 | 5,984 | 5.9 K to 6 K (+1.23 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 9.71 | 193 | 1,874 | 193 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 8.25 | 193 | 1,592 | 1,319 | 1.1 K to 1.3 K (+17.14 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.71 | 193 | 1,874 | 193 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.25 | 193 | 1,592 | 2,592 | 2.4 K to 2.6 K (+8.05 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.71 | 96 | 932 | 96 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.25 | 96 | 792 | 78,520 | 78.4 K to 78.5 K (+0.12 %) |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.71 | 69 | 670 | 69 | |
| Jun 18 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 8.25 | 69 | 569 | 5,911 | 5.8 K to 5.9 K (+1.18 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 5.39 | 126 | 679 | 126 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 4.58 | 126 | 577 | 5,842 | 5.7 K to 5.8 K (+2.20 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.39 | 174 | 938 | 174 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 4.58 | 174 | 797 | 78,424 | 78.3 K to 78.4 K (+0.22 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 5.39 | 347 | 1,870 | 347 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 4.58 | 347 | 1,589 | 1,126 | 779 to 1.1 K (+44.54 %) |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.39 | 347 | 1,870 | 347 | |
| Jun 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 4.58 | 347 | 1,589 | 2,399 | 2.1 K to 2.4 K (+16.91 %) |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.57 | 285 | 1,872 | 285 | |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.58 | 285 | 1,590 | 779 | 494 to 779 (+57.69 %) |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.57 | 102 | 670 | 102 | |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.58 | 102 | 569 | 5,716 | 5.6 K to 5.7 K (+1.82 %) |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.57 | 285 | 1,872 | 285 | |
| May 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.58 | 285 | 1,590 | 2,052 | 1.8 K to 2.1 K (+16.13 %) |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 8.05 | 233 | 1,876 | 233 | |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 6.84 | 233 | 1,594 | 1,767 | 1.5 K to 1.8 K (+15.19 %) |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 8.05 | 116 | 934 | 116 | |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 6.84 | 116 | 793 | 78,107 | 78 K to 78.1 K (+0.15 %) |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 8.05 | 84 | 676 | 84 | |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 6.84 | 84 | 575 | 5,614 | 5.5 K to 5.6 K (+1.52 %) |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 8.05 | 233 | 1,876 | 233 | |
| May 02 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 6.84 | 233 | 1,594 | 494 | 261 to 494 (+89.27 %) |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 7.16 | 94 | 673 | 94 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 6.09 | 94 | 572 | 5,530 | 5.4 K to 5.5 K (+1.73 %) |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 7.16 | 261 | 1,869 | 261 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 6.09 | 261 | 1,589 | 261 | 0 to 261 |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 7.16 | 2 | 14 | 2 | |
| Apr 17 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 6.09 | 2 | 12 | 1,263,895 | 1.3 M to 1.3 M (0.00 %) |